US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Connect Biopharma Holdings Ltd.

0.9500

+0.100011.76%

Post-market: 0.95000.00000.00%19:44 EDT

Volume:457.76K

Turnover:420.29K

Market Cap:52.78M

PE:-3.05

High:0.9600

Open:0.8480

Low:0.8480

Close:0.8500

Loading ...

Overview Company News Filings

Connect Biopharma Unveils Promising Data for Rademikibart in Asthma and COPD Phase 2 Studies, Topline Results Expected 1H26

Connect Biopharma Coverage Assumed by HC Wainwright & Co. at Buy

Connect Biopharma Holdings Ltd : H.c. Wainwright Assumes Coverage With Buy Rating; Target Price $7

THOMSON REUTERS

Connect Biopharma Files $300 Million Mixed Shelf

MT Newswires Live

Connect Biopharma: Files for Mixed Shelf Offering of up to $300 Mln - SEC Filing

THOMSON REUTERS

Connect Biopharma Unveils Presentation on Rademikibart's Potential in Treating Acute Exacerbations in Asthma and COPD

Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (Eaaci) 2025 Annual Congress

THOMSON REUTERS

Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress

Connect Biopharma Advances Asthma and COPD Treatments

Connect Biopharma Unveils Corporate Presentation Highlighting Rademikibart's Clinical Progress and Market Potential

Connect Biopharma Hldgs Q1 EPS $(0.19) Down From $(0.16) YoY

Connect Biopharma - Holds $84 Mln in Cash and Investments as of March 31

THOMSON REUTERS

Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update

THOMSON REUTERS

Connect Biopharma- Has Cash Runway Into 2027 Through Key Clinical Catalysts

THOMSON REUTERS

Press Release: Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update

Connect Biopharma Launches Phase 2 COPD Study

Connect Biopharma Initiates Phase 2 Seabreeze Stat Copd Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Copd

THOMSON REUTERS

Connect Biopharma initiates Phase 2 Seabreeze STAT Asthma study

Connect Biopharma Launches Phase 2 Seabreeze STAT Asthma Study to Evaluate Rademikibart for Acute Exacerbations in Asthma

Connect Biopharma Holdings Ltd: Expect to Report Topline Data From Seabreeze Stat Asthma Study in 1H 2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CNTB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNTB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNTB\",,,,,undefined,":{"symbol":"CNTB","market":"US","secType":"STK","nameCN":"Connect Biopharma Holdings Ltd.","latestPrice":0.95,"timestamp":1749844800000,"preClose":0.85,"halted":0,"volume":457759,"hourTrading":{"tag":"盘后","latestPrice":0.95,"preClose":0.95,"latestTime":"19:44 EDT","volume":124,"amount":120.0627,"timestamp":1749858262440},"delay":0,"floatShares":14373506,"shares":55561056,"eps":-0.311296,"marketStatus":"Closed","change":0.1,"latestTime":"06-13 16:00:00 EDT","open":0.848,"high":0.96,"low":0.848,"amount":420290.72090114,"amplitude":0.131765,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.311296,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":5,"adr":0,"adrRate":1,"listingDate":1616126400000,"exchange":"NASDAQ","adjPreClose":0.85,"preHourTrading":{"tag":"盘前","latestPrice":0.82,"preClose":0.85,"latestTime":"08:22 EDT","volume":422,"amount":347.29999494,"timestamp":1749817375749},"postHourTrading":{"tag":"盘后","latestPrice":0.95,"preClose":0.95,"latestTime":"19:44 EDT","volume":124,"amount":120.0627,"timestamp":1749858262440},"volumeRatio":10.32058,"impliedVol":0.8202,"impliedVolPercentile":0.936},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNTB\",,,,,undefined,":{"symbol":"CNTB","floatShares":14373506,"roa":"-12.47%","roe":"-18.66%","lyrEps":-0.283049,"volumeRatio":10.32058,"shares":55561056,"dividePrice":0,"high":0.96,"amplitude":0.131765,"preClose":0.85,"low":0.848,"week52Low":0.51,"pbRate":"0.64","psRate":"2.03","week52High":1.79,"institutionHeld":0,"latestPrice":0.95,"eps":-0.311296,"divideRate":0,"volume":457759,"delay":0,"ttmEps":-0.311296,"open":0.848,"prevYearClose":1.38,"prevWeekClose":0.7915,"prevMonthClose":0.84,"prevQuarterClose":0.55,"fiveDayClose":0.7915,"twentyDayClose":0.727,"sixtyDayClose":0.8},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNTB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543687843","title":"Connect Biopharma Unveils Promising Data for Rademikibart in Asthma and COPD Phase 2 Studies, Topline Results Expected 1H26","url":"https://stock-news.laohu8.com/highlight/detail?id=2543687843","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543687843?lang=en_us&edition=fundamental","pubTime":"2025-06-13 21:00","pubTimestamp":1749819628,"startTime":"0","endTime":"0","summary":"SAN DIEGO, June 13, 2025  -- Connect Biopharma Holdings Limited , a clinical-stage biopharmaceutical company, has announced the presentation of clinical data supporting their investigational drug, rademikibart, at the European Academy of Allergy and Clinical Immunology  2025 Annual Congress. The data, which demonstrates rademikibart's potential to significantly improve lung function and reduce annualized exacerbations in patients with eosinophilic-driven type 2 asthma, will be available from June 13-16, 2025, in Glasgow, United Kingdom, and virtually. These findings support ongoing Phase 2 acute exacerbation studies in asthma and chronic obstructive pulmonary disease , with topline data expected in the first half of 2026. Presentations are accessible on Connect Biopharma's website under the presentations and publications section.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely inf","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nNDL2XcTqR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2210150020.SGD","BK4139","BK4585","BK4588","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4112","NDAQ","CNTB","LU2095319765.USD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2542151915","title":"Connect Biopharma Coverage Assumed by HC Wainwright & Co. at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2542151915","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542151915?lang=en_us&edition=fundamental","pubTime":"2025-06-12 19:09","pubTimestamp":1749726540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNTB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 12, 2025 07:09 ET (11:09 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"gpt_icon":0},{"id":"2542627518","title":"Connect Biopharma Holdings Ltd : H.c. Wainwright Assumes Coverage With Buy  Rating; Target Price $7","url":"https://stock-news.laohu8.com/highlight/detail?id=2542627518","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542627518?lang=en_us&edition=fundamental","pubTime":"2025-06-12 18:16","pubTimestamp":1749723419,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nFWN3SE0O3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNTB"],"gpt_icon":0},{"id":"2542222340","title":"Connect Biopharma Files $300 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2542222340","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542222340?lang=en_us&edition=fundamental","pubTime":"2025-06-11 04:58","pubTimestamp":1749589122,"startTime":"0","endTime":"0","summary":"Connect Biopharma  on Tuesday filed a registration statement for the sale of up to $300 million of its securities from time to time in one or more offerings.The filing covers ordinary shares, American depositary shares, preferred shares, debt securities, warrants, purchase contracts and units.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CNTB"],"gpt_icon":0},{"id":"2542354340","title":"Connect Biopharma: Files for Mixed Shelf Offering of up to $300 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2542354340","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542354340?lang=en_us&edition=fundamental","pubTime":"2025-06-11 04:37","pubTimestamp":1749587843,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nFWN3SD06L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNTB","BK4139"],"gpt_icon":0},{"id":"2540632640","title":"Connect Biopharma Unveils Presentation on Rademikibart's Potential in Treating Acute Exacerbations in Asthma and COPD","url":"https://stock-news.laohu8.com/highlight/detail?id=2540632640","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540632640?lang=en_us&edition=fundamental","pubTime":"2025-06-04 20:03","pubTimestamp":1749038592,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings Ltd. has released a corporate presentation detailing their advancements in drug development, specifically focusing on Rademikibart, an anti-IL-4Rα monoclonal antibody. The presentation highlights the company's experienced U.S. management team, assembled in the second half of 2024, which is dedicated to progressing Rademikibart for the treatment of eosinophilic driven respiratory diseases. The company has initiated Phase 2 studies for Rademikibart targeting acute exacerbations in asthma and COPD, with data expected in the first half of 2026. Market research indicates that Rademikibart could significantly outperform existing biologics like dupilumab, especially due to its potential use in acute exacerbation indications. The presentation outlines plans for ongoing studies and anticipates exclusivity for Rademikibart through at least 2040. Connect Biopharma retains global development and commercialization rights outside of greater China. You can access the full p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL7rjVjj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"gpt_icon":0},{"id":"2540774654","title":"Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (Eaaci) 2025 Annual Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2540774654","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540774654?lang=en_us&edition=fundamental","pubTime":"2025-06-03 21:00","pubTimestamp":1748955600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nTUA8T53VS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNTB","BK4139"],"gpt_icon":0},{"id":"2541877095","title":"Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2541877095","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541877095?lang=en_us&edition=fundamental","pubTime":"2025-06-03 21:00","pubTimestamp":1748955600,"startTime":"0","endTime":"0","summary":"SAN DIEGO, June 03, 2025  -- Connect Biopharma Holdings Limited  , a clinical-stage biopharmaceutical company focused on transforming acute and chronic care of asthma and chronic obstructive pulmonary disease , today announced two oral presentations at the European Academy of Allergy and Clinical Immunology  2025 Annual Congress, taking placeJune 13-16, 2025, inGlasgow, United Kingdom and virtually.Abstract Title: Reduction in Annualized Exacerbations with Rademikibart in Eosinophilic Driven, Type 2 AsthmaAbstract Number: 001671Presenter: Rekha Chaudhuri, M.D.Session Title: Clinical Trials on Airways DiseasesDate and Time: Friday, June 13th from 3:00 p.m. – 4:30 p.m. BST. Following the presentations, each presentation will be available on Connect’s website under the presentations and publications section.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/connect-biopharma-announces-two-oral-130000453.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","CNTB"],"gpt_icon":0},{"id":"2536372563","title":"Connect Biopharma Advances Asthma and COPD Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2536372563","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536372563?lang=en_us&edition=fundamental","pubTime":"2025-05-17 11:59","pubTimestamp":1747454370,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings Ltd. ( ($CNTB) ) has released its Q1 earnings. Here is a breakdown of the information Connect Biopharma Holdings Ltd. pr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/connect-biopharma-advances-asthma-and-copd-treatments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/connect-biopharma-advances-asthma-and-copd-treatments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNTB","BK4139"],"gpt_icon":0},{"id":"2535872694","title":"Connect Biopharma Unveils Corporate Presentation Highlighting Rademikibart's Clinical Progress and Market Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2535872694","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535872694?lang=en_us&edition=fundamental","pubTime":"2025-05-16 03:09","pubTimestamp":1747336192,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings Ltd. presented its corporate presentation, highlighting significant advancements in its drug development program. The company is focused on progressing its anti-interleukin-4-receptor alpha  treatment, Rademikibart, targeting eosinophilic-driven respiratory diseases such as asthma and COPD. The presentation outlined the initiation of Phase 2 studies for acute COPD and asthma exacerbations in the U.S., with data expected in the first half of 2026. Rademikibart is noted for its potential commercial appeal, especially due to its acute exacerbation indications, which differentiate it from other biologics. The company has global development and commercialization rights outside of greater China and anticipates significant market opportunities with projected worldwide peak sales. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDL32nYTZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"gpt_icon":0},{"id":"2535280098","title":"Connect Biopharma Hldgs Q1 EPS $(0.19) Down From $(0.16) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2535280098","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535280098?lang=en_us&edition=fundamental","pubTime":"2025-05-15 21:05","pubTimestamp":1747314344,"startTime":"0","endTime":"0","summary":"Connect Biopharma Hldgs (NASDAQ:CNTB) reported quarterly losses of $(0.19) per share. This is a 18.75 percent decrease over losses of $(0.16) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45436487/connect-biopharma-hldgs-q1-eps-0-19-down-from-0-16-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB"],"gpt_icon":0},{"id":"2535828751","title":"Connect Biopharma - Holds $84 Mln in Cash and Investments as of March 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2535828751","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535828751?lang=en_us&edition=fundamental","pubTime":"2025-05-15 21:00","pubTimestamp":1747314005,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nTUA9Y0QF0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNTB"],"gpt_icon":0},{"id":"2535828425","title":"Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2535828425","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535828425?lang=en_us&edition=fundamental","pubTime":"2025-05-15 21:00","pubTimestamp":1747314005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nTUA9Y0QF0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNTB"],"gpt_icon":0},{"id":"2535755828","title":"Connect Biopharma- Has Cash Runway Into 2027 Through Key Clinical Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2535755828","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535755828?lang=en_us&edition=fundamental","pubTime":"2025-05-15 21:00","pubTimestamp":1747314005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nTUA9Y0QF0:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNTB"],"gpt_icon":0},{"id":"2535828197","title":"Press Release: Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2535828197","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535828197?lang=en_us&edition=fundamental","pubTime":"2025-05-15 21:00","pubTimestamp":1747314000,"startTime":"0","endTime":"0","summary":"Initiated Phase 2 Seabreeze STAT Asthma and Seabreeze STAT COPD studies evaluating rademikibart as an adjunct treatment for acute exacerbations in Asthma and COPD in May 2025; topline data expected in 1H 2026. Published positive data from its global Phase 2 study supporting potential of rademikibart as a novel biologic treatment for patients with asthma and Type 2 inflammation. Strong balance sheet with cash runway into 2027 through key clinical catalysts. SAN DIEGO, May 15, 2025  -- Connect Biopharma Holdings Limited  , a clinical-stage biopharmaceutical company focused on transforming acute and chronic care of asthma and chronic obstructive pulmonary disease , today reported financial results for the three months ended March 31, 2025, and provided a business update.-- Executing on rapid clinical development program for rademikibart as an. -- Initiated Phase 2 Seabreeze STAT asthma study evaluating the. safety and efficacy of rademikibart for acute exacerbations in. adolescents and ad","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","CNTB","BK4139","ATS"],"gpt_icon":0},{"id":"2535208490","title":"Connect Biopharma Launches Phase 2 COPD Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2535208490","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535208490?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:28","pubTimestamp":1747229280,"startTime":"0","endTime":"0","summary":"An update from Connect Biopharma Holdings ( ($CNTB) ) is now available. On May 14, 2025, Connect Biopharma announced the initiation of its Phase 2 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/connect-biopharma-launches-phase-2-copd-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/connect-biopharma-launches-phase-2-copd-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CNTB"],"gpt_icon":0},{"id":"2535402494","title":"Connect Biopharma Initiates Phase 2 Seabreeze Stat Copd Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Copd","url":"https://stock-news.laohu8.com/highlight/detail?id=2535402494","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535402494?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:00","pubTimestamp":1747227601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nTUA2RNQ5Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNTB"],"gpt_icon":0},{"id":"2535377981","title":"Connect Biopharma initiates Phase 2 Seabreeze STAT Asthma study","url":"https://stock-news.laohu8.com/highlight/detail?id=2535377981","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535377981?lang=en_us&edition=fundamental","pubTime":"2025-05-13 21:14","pubTimestamp":1747142063,"startTime":"0","endTime":"0","summary":"Connect Biopharma (CNTB) announced the initiation of its Phase 2 Seabreeze STAT Asthma study following written agreement on the final study protoco...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/connect-biopharma-initiates-phase-2-seabreeze-stat-asthma-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/connect-biopharma-initiates-phase-2-seabreeze-stat-asthma-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNTB","BK4139"],"gpt_icon":0},{"id":"2535775999","title":"Connect Biopharma Launches Phase 2 Seabreeze STAT Asthma Study to Evaluate Rademikibart for Acute Exacerbations in Asthma","url":"https://stock-news.laohu8.com/highlight/detail?id=2535775999","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535775999?lang=en_us&edition=fundamental","pubTime":"2025-05-13 21:00","pubTimestamp":1747141223,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings Ltd., a clinical-stage biopharmaceutical company, has announced the initiation of its Phase 2 Seabreeze STAT Asthma study to evaluate the safety and efficacy of rademikibart for treating acute exacerbations in asthma. This study, which is expected to report topline data in the first half of 2026, aims to establish rademikibart as a potentially groundbreaking biologic treatment for patients experiencing acute asthma exacerbations. Following positive results from a previous global Phase 2 trial, rademikibart has demonstrated the ability to rapidly improve lung function within 24 hours and provide sustained improvements over 24 weeks. The company is also set to begin a similarly-designed Phase 2 study for COPD patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDL203tJC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2210150020.SGD","IE00B64PRP62.GBP","LU2095319765.USD","BK4588","CNTB","BK4585","BK4112","LU2210149790.SGD","BK4139","IE00BKPKM429.USD","NDAQ","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2535977520","title":"Connect Biopharma Holdings Ltd: Expect to Report Topline Data From Seabreeze Stat Asthma Study in 1H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2535977520","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535977520?lang=en_us&edition=fundamental","pubTime":"2025-05-13 21:00","pubTimestamp":1747141204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA7YLJJM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNTB","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNTB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"CNTB","fiscalQuarterEnding":"2025/03","expectedEps":-0.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.19},{"date":"2025-03-31","symbol":"CNTB","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743408000000,"name":null,"time":"Pre-Market","dateTimestamp":1743393600000,"actualEps":null},{"date":"2024-09-05","symbol":"CNTB","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1725566400000,"name":null,"time":"Post Market","dateTimestamp":1725508800000,"actualEps":null},{"market":"US","date":"2024-04-16","symbol":"CNTB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713240000000,"reportTimeType":"post","actualEps":null},{"date":"2023-09-12","symbol":"CNTB","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1694548800000,"name":null,"time":"Post Market","dateTimestamp":1694491200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNTB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNTB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1738814400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNTB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNTB","date":"2025-06-12","current":-2.644534,"percent":0.263566,"low":-12.632535,"twenty":-3.0628,"median":-0.920472,"eighty":-0.495453,"high":-0.159163,"avg":-2.105931,"sd":2.512846,"marketCap":45504504},"quantilePoints":[{"date":"2021-03-19","current":-8.225201,"twenty":-7.997774,"median":-7.656633,"eighty":-7.655009,"marketCap":984650040},{"date":"2021-03-26","current":-7.10826,"twenty":-7.997774,"median":-7.561124,"eighty":-7.121039,"marketCap":846724480},{"date":"2021-04-01","current":-8.009059,"twenty":-8.181973,"median":-7.567257,"eighty":-7.178084,"marketCap":950568049},{"date":"2021-04-09","current":-7.612804,"twenty":-8.0273,"median":-7.632136,"eighty":-7.332162,"marketCap":905302904},{"date":"2021-04-16","current":-7.696063,"twenty":-7.97235,"median":-7.643031,"eighty":-7.367612,"marketCap":919681244},{"date":"2021-04-23","current":-7.156707,"twenty":-7.817836,"median":-7.629019,"eighty":-7.367612,"marketCap":858440165},{"date":"2021-04-30","current":-7.199728,"twenty":-7.771758,"median":-7.587406,"eighty":-7.165311,"marketCap":866428132},{"date":"2021-05-07","current":-6.8278,"twenty":-7.707419,"median":-7.579293,"eighty":-7.142023,"marketCap":827020829},{"date":"2021-05-14","current":-7.219178,"twenty":-7.690632,"median":-7.454798,"eighty":-7.108845,"marketCap":873883567},{"date":"2021-05-21","current":-6.833256,"twenty":-7.666455,"median":-7.329594,"eighty":-7.106536,"marketCap":827553360},{"date":"2021-05-28","current":-6.476128,"twenty":-7.656092,"median":-7.217636,"eighty":-6.852745,"marketCap":792406306},{"date":"2021-06-04","current":-6.472584,"twenty":-7.653926,"median":-7.178218,"eighty":-6.8278,"marketCap":788678588},{"date":"2021-06-11","current":-7.871174,"twenty":-7.66891,"median":-7.199728,"eighty":-6.8278,"marketCap":958556016},{"date":"2021-06-18","current":-7.761814,"twenty":-7.761814,"median":-7.272517,"eighty":-6.833256,"marketCap":937254771},{"date":"2021-06-25","current":-8.391559,"twenty":-7.85715,"median":-7.342434,"eighty":-6.834202,"marketCap":1012874190},{"date":"2021-07-02","current":-8.71754,"twenty":-7.959493,"median":-7.474455,"eighty":-6.847608,"marketCap":1049618837},{"date":"2021-07-09","current":-9.134734,"twenty":-8.156045,"median":-7.580053,"eighty":-6.868157,"marketCap":1098611700},{"date":"2021-07-16","current":-9.741359,"twenty":-8.289207,"median":-7.588517,"eighty":-6.907112,"marketCap":1171568464},{"date":"2021-07-23","current":-11.516599,"twenty":-8.530315,"median":-7.620912,"eighty":-6.924109,"marketCap":1384580912},{"date":"2021-07-30","current":-9.719612,"twenty":-8.829681,"median":-7.653926,"eighty":-7.067431,"marketCap":1172100995},{"date":"2021-08-06","current":-9.614005,"twenty":-9.492154,"median":-7.682486,"eighty":-7.105429,"marketCap":1155592530},{"date":"2021-08-13","current":-10.407078,"twenty":-9.721345,"median":-7.761814,"eighty":-7.107829,"marketCap":1251980663},{"date":"2021-08-20","current":-9.903891,"twenty":-9.749231,"median":-7.806323,"eighty":-7.110602,"marketCap":1187011866},{"date":"2021-08-27","current":-8.014295,"twenty":-9.749231,"median":-7.866236,"eighty":-7.118423,"marketCap":964946389},{"date":"2021-09-03","current":-5.186666,"twenty":-9.732952,"median":-7.841331,"eighty":-7.105429,"marketCap":1322919109},{"date":"2021-09-10","current":-4.62158,"twenty":-9.729307,"median":-7.778196,"eighty":-6.898658,"marketCap":1180817978},{"date":"2021-09-17","current":-4.801642,"twenty":-9.723079,"median":-7.710258,"eighty":-6.831074,"marketCap":1222705998},{"date":"2021-09-24","current":-4.489307,"twenty":-9.696523,"median":-7.662771,"eighty":-6.554186,"marketCap":1143171783},{"date":"2021-10-01","current":-4.843137,"twenty":-9.645339,"median":-7.632136,"eighty":-6.431352,"marketCap":1237022157},{"date":"2021-10-08","current":-3.807848,"twenty":-9.620408,"median":-7.603768,"eighty":-6.251971,"marketCap":972968563},{"date":"2021-10-15","current":-3.558007,"twenty":-9.616281,"median":-7.586295,"eighty":-5.019272,"marketCap":910401647},{"date":"2021-10-22","current":-3.355537,"twenty":-9.566602,"median":-7.52994,"eighty":-4.833909,"marketCap":865332259},{"date":"2021-10-29","current":-3.267452,"twenty":-9.502865,"median":-7.441275,"eighty":-4.780728,"marketCap":839881310},{"date":"2021-11-05","current":-3.253783,"twenty":-9.469894,"median":-7.327725,"eighty":-4.593046,"marketCap":837230169},{"date":"2021-11-12","current":-2.966436,"twenty":-9.453591,"median":-7.216094,"eighty":-4.483697,"marketCap":765649376},{"date":"2021-11-19","current":-1.053194,"twenty":-9.259982,"median":-7.152997,"eighty":-4.330678,"marketCap":271476787},{"date":"2021-11-26","current":-0.926282,"twenty":-9.13122,"median":-7.138841,"eighty":-4.174663,"marketCap":238602645},{"date":"2021-12-03","current":-0.915809,"twenty":-9.086801,"median":-7.12805,"eighty":-3.589981,"marketCap":236481732},{"date":"2021-12-10","current":-0.890151,"twenty":-8.969361,"median":-7.109723,"eighty":-3.473393,"marketCap":230118995},{"date":"2021-12-17","current":-0.932161,"twenty":-8.830139,"median":-7.102727,"eighty":-3.378137,"marketCap":240723557},{"date":"2021-12-23","current":-0.943664,"twenty":-8.746242,"median":-6.915567,"eighty":-3.258613,"marketCap":243904926},{"date":"2021-12-31","current":-1.05356,"twenty":-8.697693,"median":-6.840905,"eighty":-3.199128,"marketCap":273067471},{"date":"2022-01-07","current":-0.946776,"twenty":-8.615675,"median":-6.8278,"eighty":-2.990554,"marketCap":244435154},{"date":"2022-01-14","current":-1.051564,"twenty":-8.586449,"median":-6.62613,"eighty":-2.739352,"marketCap":272537243},{"date":"2022-01-21","current":-1.000269,"twenty":-8.511604,"median":-6.513569,"eighty":-2.490275,"marketCap":259811769},{"date":"2022-01-28","current":-0.878785,"twenty":-8.391559,"median":-6.439938,"eighty":-1.053194,"marketCap":227467854},{"date":"2022-02-04","current":-1.01194,"twenty":-8.317939,"median":-6.3296,"eighty":-1.046595,"marketCap":261932681},{"date":"2022-02-11","current":-0.914897,"twenty":-8.307941,"median":-6.197118,"eighty":-1.013637,"marketCap":237011960},{"date":"2022-02-18","current":-0.918769,"twenty":-8.284524,"median":-5.043435,"eighty":-1.005795,"marketCap":239132873},{"date":"2022-02-25","current":-0.764942,"twenty":-8.278042,"median":-5.000788,"eighty":-0.982029,"marketCap":199365765},{"date":"2022-03-04","current":-0.826184,"twenty":-8.235445,"median":-4.843137,"eighty":-0.964922,"marketCap":215272608},{"date":"2022-03-11","current":-0.634904,"twenty":-8.186332,"median":-4.812188,"eighty":-0.954055,"marketCap":164900939},{"date":"2022-03-18","current":-1.01402,"twenty":-8.156045,"median":-4.749358,"eighty":-0.948264,"marketCap":262462909},{"date":"2022-03-25","current":-0.633398,"twenty":-8.055669,"median":-4.610802,"eighty":-0.938787,"marketCap":163840482},{"date":"2022-04-01","current":-0.817881,"twenty":-8.017808,"median":-4.56151,"eighty":-0.931801,"marketCap":167982772},{"date":"2022-04-08","current":-0.769746,"twenty":-8.010106,"median":-4.482295,"eighty":-0.925482,"marketCap":158069035},{"date":"2022-04-14","current":-0.768664,"twenty":-7.979319,"median":-4.405731,"eighty":-0.918413,"marketCap":157518272},{"date":"2022-04-22","current":-0.739819,"twenty":-7.913151,"median":-4.287019,"eighty":-0.914458,"marketCap":148706061},{"date":"2022-04-29","current":-0.56539,"twenty":-7.875607,"median":-4.176153,"eighty":-0.900786,"marketCap":111804927},{"date":"2022-05-06","current":-0.17557,"twenty":-7.868211,"median":-3.670547,"eighty":-0.888287,"marketCap":34417191},{"date":"2022-05-13","current":-0.214562,"twenty":-7.860784,"median":-3.53283,"eighty":-0.874894,"marketCap":41307239},{"date":"2022-05-20","current":-0.256686,"twenty":-7.838167,"median":-3.475686,"eighty":-0.852444,"marketCap":50119450},{"date":"2022-05-27","current":-0.239989,"twenty":-7.802485,"median":-3.447182,"eighty":-0.827995,"marketCap":46814871},{"date":"2022-06-03","current":-0.222507,"twenty":-7.779984,"median":-3.383787,"eighty":-0.815856,"marketCap":43658998},{"date":"2022-06-10","current":-0.234674,"twenty":-7.766282,"median":-3.267452,"eighty":-0.803106,"marketCap":45713344},{"date":"2022-06-17","current":-0.214333,"twenty":-7.741192,"median":-3.248328,"eighty":-0.783474,"marketCap":41701960},{"date":"2022-06-24","current":-0.253451,"twenty":-7.707419,"median":-3.211747,"eighty":-0.770941,"marketCap":49514201},{"date":"2022-07-01","current":-0.255161,"twenty":-7.690632,"median":-3.158228,"eighty":-0.76458,"marketCap":49761772},{"date":"2022-07-08","current":-0.245152,"twenty":-7.66891,"median":-2.966436,"eighty":-0.74871,"marketCap":47863727},{"date":"2022-07-15","current":-0.258726,"twenty":-7.656633,"median":-2.926464,"eighty":-0.68542,"marketCap":50036851},{"date":"2022-07-22","current":-0.234638,"twenty":-7.653926,"median":-2.676357,"eighty":-0.656046,"marketCap":45415525},{"date":"2022-07-29","current":-0.231464,"twenty":-7.632136,"median":-1.85068,"eighty":-0.633398,"marketCap":44848863},{"date":"2022-08-05","current":-0.375753,"twenty":-7.629019,"median":-1.05356,"eighty":-0.56539,"marketCap":72620828},{"date":"2022-08-12","current":-0.397407,"twenty":-7.612804,"median":-1.051572,"eighty":-0.51804,"marketCap":77022090},{"date":"2022-08-19","current":-0.393211,"twenty":-7.594732,"median":-1.046595,"eighty":-0.451463,"marketCap":75371617},{"date":"2022-08-26","current":-0.428161,"twenty":-7.588517,"median":-1.025955,"eighty":-0.413444,"marketCap":81423352},{"date":"2022-09-02","current":-0.389232,"twenty":-7.586295,"median":-1.013637,"eighty":-0.408638,"marketCap":73721143},{"date":"2022-09-09","current":-0.408187,"twenty":-7.581909,"median":-1.011955,"eighty":-0.403502,"marketCap":77022090},{"date":"2022-09-16","current":-0.723373,"twenty":-7.579597,"median":-1.003032,"eighty":-0.405606,"marketCap":79222721},{"date":"2022-09-23","current":-0.60438,"twenty":-7.500328,"median":-0.983258,"eighty":-0.407767,"marketCap":64918619},{"date":"2022-09-30","current":-0.659467,"twenty":-7.470775,"median":-0.967989,"eighty":-0.408548,"marketCap":70970354},{"date":"2022-10-07","current":-0.552143,"twenty":-7.446684,"median":-0.964367,"eighty":-0.409978,"marketCap":59417041},{"date":"2022-10-14","current":-0.488722,"twenty":-7.362202,"median":-0.955013,"eighty":-0.410887,"marketCap":52033923},{"date":"2022-10-21","current":-0.475948,"twenty":-7.332162,"median":-0.951472,"eighty":-0.412961,"marketCap":50328434},{"date":"2022-10-28","current":-0.454861,"twenty":-7.326603,"median":-0.94522,"eighty":-0.415335,"marketCap":48017771},{"date":"2022-11-04","current":-0.373701,"twenty":-7.240513,"median":-0.939366,"eighty":-0.415335,"marketCap":39831423},{"date":"2022-11-11","current":-0.352484,"twenty":-7.216711,"median":-0.934342,"eighty":-0.408548,"marketCap":37971890},{"date":"2022-11-18","current":-0.377052,"twenty":-7.203001,"median":-0.930363,"eighty":-0.402747,"marketCap":40546629},{"date":"2022-11-25","current":-0.382688,"twenty":-7.173915,"median":-0.926282,"eighty":-0.397285,"marketCap":40860219},{"date":"2022-12-02","current":-0.361406,"twenty":-7.152256,"median":-0.920821,"eighty":-0.383534,"marketCap":39418805},{"date":"2022-12-09","current":-0.358359,"twenty":-7.143839,"median":-0.918109,"eighty":-0.380898,"marketCap":39440811},{"date":"2022-12-16","current":-0.350715,"twenty":-7.138568,"median":-0.915353,"eighty":-0.380898,"marketCap":38516546},{"date":"2022-12-23","current":-0.379125,"twenty":-7.1364,"median":-0.908751,"eighty":-0.378676,"marketCap":41542469},{"date":"2022-12-30","current":-0.430096,"twenty":-7.13263,"median":-0.90479,"eighty":-0.377809,"marketCap":47742693},{"date":"2023-01-06","current":-0.417597,"twenty":-7.126486,"median":-0.891571,"eighty":-0.378227,"marketCap":46763412},{"date":"2023-01-13","current":-0.476852,"twenty":-7.118423,"median":-0.887821,"eighty":-0.379443,"marketCap":54410605},{"date":"2023-01-20","current":-0.526363,"twenty":-7.111187,"median":-0.881989,"eighty":-0.380713,"marketCap":59417041},{"date":"2023-01-27","current":-0.623924,"twenty":-7.10826,"median":-0.873573,"eighty":-0.381022,"marketCap":70420197},{"date":"2023-02-03","current":-0.558865,"twenty":-7.106105,"median":-0.856826,"eighty":-0.38112,"marketCap":63273647},{"date":"2023-02-10","current":-0.54294,"twenty":-7.102727,"median":-0.842419,"eighty":-0.381865,"marketCap":61067514},{"date":"2023-02-17","current":-0.528021,"twenty":-6.926245,"median":-0.827693,"eighty":-0.382688,"marketCap":58866883},{"date":"2023-02-24","current":-0.569815,"twenty":-6.917703,"median":-0.817662,"eighty":-0.383186,"marketCap":62717988},{"date":"2023-03-03","current":-0.610413,"twenty":-6.881749,"median":-0.808922,"eighty":-0.383608,"marketCap":67669408},{"date":"2023-03-10","current":-0.527318,"twenty":-6.852745,"median":-0.803422,"eighty":-0.384285,"marketCap":58316725},{"date":"2023-03-17","current":-0.544298,"twenty":-6.836883,"median":-0.794928,"eighty":-0.388273,"marketCap":60517356},{"date":"2023-03-24","current":-0.473741,"twenty":-6.833445,"median":-0.778365,"eighty":-0.390596,"marketCap":52815147},{"date":"2023-03-31","current":-0.493552,"twenty":-6.828891,"median":-0.769746,"eighty":-0.391232,"marketCap":55010277},{"date":"2023-04-06","current":-0.52866,"twenty":-6.807965,"median":-0.768585,"eighty":-0.392449,"marketCap":58866883},{"date":"2023-04-14","current":-0.536009,"twenty":-6.73547,"median":-0.762362,"eighty":-0.395546,"marketCap":62196609},{"date":"2023-04-21","current":-0.498318,"twenty":-6.612165,"median":-0.74871,"eighty":-0.397285,"marketCap":57793309},{"date":"2023-04-28","current":-0.497275,"twenty":-6.553128,"median":-0.731818,"eighty":-0.399415,"marketCap":57242896},{"date":"2023-05-05","current":-0.544069,"twenty":-6.506081,"median":-0.709336,"eighty":-0.401809,"marketCap":62747021},{"date":"2023-05-11","current":-0.556594,"twenty":-6.47471,"median":-0.701012,"eighty":-0.40263,"marketCap":63847846},{"date":"2023-05-19","current":-0.588283,"twenty":-6.459526,"median":-0.687882,"eighty":-0.403154,"marketCap":66599908},{"date":"2023-05-26","current":-0.566751,"twenty":-6.431352,"median":-0.678549,"eighty":-0.404244,"marketCap":63847846},{"date":"2023-06-02","current":-0.543961,"twenty":-6.418474,"median":-0.672932,"eighty":-0.405096,"marketCap":61095784},{"date":"2023-06-08","current":-0.554893,"twenty":-6.355881,"median":-0.659873,"eighty":-0.40589,"marketCap":62196609},{"date":"2023-06-16","current":-0.497477,"twenty":-6.327473,"median":-0.655458,"eighty":-0.407348,"marketCap":55591659},{"date":"2023-06-23","current":-0.614773,"twenty":-6.306796,"median":-0.649124,"eighty":-0.408367,"marketCap":68251146},{"date":"2023-06-30","current":-0.555865,"twenty":-6.294625,"median":-0.644385,"eighty":-0.408548,"marketCap":61095784},{"date":"2023-07-06","current":-0.575855,"twenty":-6.270255,"median":-0.64183,"eighty":-0.408973,"marketCap":63297434},{"date":"2023-07-14","current":-0.558006,"twenty":-6.197118,"median":-0.634151,"eighty":-0.410313,"marketCap":62196609},{"date":"2023-07-21","current":-0.535216,"twenty":-5.186666,"median":-0.627919,"eighty":-0.411031,"marketCap":59444546},{"date":"2023-07-28","current":-0.495387,"twenty":-5.058382,"median":-0.626447,"eighty":-0.411478,"marketCap":55041247},{"date":"2023-08-04","current":-0.475069,"twenty":-5.028488,"median":-0.624235,"eighty":-0.413444,"marketCap":52839597},{"date":"2023-08-11","current":-0.463522,"twenty":-5.005447,"median":-0.623221,"eighty":-0.415808,"marketCap":51188359},{"date":"2023-08-18","current":-0.453142,"twenty":-4.996129,"median":-0.614773,"eighty":-0.416116,"marketCap":49537122},{"date":"2023-08-25","current":-0.412067,"twenty":-4.883081,"median":-0.606902,"eighty":-0.415808,"marketCap":45133822},{"date":"2023-09-01","current":-0.413906,"twenty":-4.843137,"median":-0.600278,"eighty":-0.412385,"marketCap":45453061},{"date":"2023-09-08","current":-0.394786,"twenty":-4.824681,"median":-0.597524,"eighty":-0.411389,"marketCap":42937676},{"date":"2023-09-15","current":-0.553612,"twenty":-4.814942,"median":-0.596714,"eighty":-0.410887,"marketCap":46234647},{"date":"2023-09-22","current":-0.431749,"twenty":-4.811303,"median":-0.589983,"eighty":-0.411389,"marketCap":35906656},{"date":"2023-09-29","current":-0.493437,"twenty":-4.803456,"median":-0.588992,"eighty":-0.411949,"marketCap":41072368},{"date":"2023-10-06","current":-0.621906,"twenty":-4.759815,"median":-0.589869,"eighty":-0.412067,"marketCap":51767265},{"date":"2023-10-13","current":-0.582179,"twenty":-4.685168,"median":-0.589926,"eighty":-0.412321,"marketCap":48462971},{"date":"2023-10-20","current":-0.782186,"twenty":-4.631088,"median":-0.595176,"eighty":-0.412783,"marketCap":64984439},{"date":"2023-10-27","current":-0.758864,"twenty":-4.617269,"median":-0.595506,"eighty":-0.412995,"marketCap":63034906},{"date":"2023-11-03","current":-0.92881,"twenty":-4.596535,"median":-0.597168,"eighty":-0.413536,"marketCap":77155254},{"date":"2023-11-10","current":-1.055984,"twenty":-4.578364,"median":-0.598624,"eighty":-0.414286,"marketCap":88114494},{"date":"2023-11-17","current":-1.305878,"twenty":-4.558808,"median":-0.604483,"eighty":-0.41587,"marketCap":109592402},{"date":"2023-11-24","current":-0.835288,"twenty":-4.548002,"median":-0.609664,"eighty":-0.416116,"marketCap":71042311},{"date":"2023-12-01","current":-0.74365,"twenty":-4.489307,"median":-0.614773,"eighty":-0.417326,"marketCap":63332292},{"date":"2023-12-08","current":-0.602179,"twenty":-4.475282,"median":-0.621384,"eighty":-0.417597,"marketCap":51216549},{"date":"2023-12-15","current":-0.49234,"twenty":-4.418471,"median":-0.610413,"eighty":-0.420523,"marketCap":42135249},{"date":"2023-12-22","current":-0.537452,"twenty":-4.392992,"median":-0.609656,"eighty":-0.421884,"marketCap":45742436},{"date":"2023-12-29","current":-0.708246,"twenty":-4.373067,"median":-0.609218,"eighty":-0.423709,"marketCap":60578714},{"date":"2024-01-05","current":-0.789997,"twenty":-4.345231,"median":-0.610101,"eighty":-0.424968,"marketCap":67187301},{"date":"2024-01-12","current":-0.739514,"twenty":-4.284263,"median":-0.614773,"eighty":-0.42546,"marketCap":62924763},{"date":"2024-01-19","current":-0.697741,"twenty":-4.273239,"median":-0.621906,"eighty":-0.426746,"marketCap":58926568},{"date":"2024-01-26","current":-0.841231,"twenty":-4.183606,"median":-0.623949,"eighty":-0.427141,"marketCap":71593026},{"date":"2024-02-02","current":-0.65717,"twenty":-4.168701,"median":-0.625511,"eighty":-0.428161,"marketCap":55622274},{"date":"2024-02-09","current":-0.719854,"twenty":-3.807848,"median":-0.627255,"eighty":-0.430096,"marketCap":61129430},{"date":"2024-02-16","current":-0.785847,"twenty":-3.670547,"median":-0.628587,"eighty":-0.430295,"marketCap":66636586},{"date":"2024-02-23","current":-0.703977,"twenty":-3.644463,"median":-0.629181,"eighty":-0.430329,"marketCap":59477283},{"date":"2024-03-01","current":-0.768787,"twenty":-3.573994,"median":-0.637061,"eighty":-0.431467,"marketCap":64984439},{"date":"2024-03-08","current":-0.782256,"twenty":-3.517724,"median":-0.642819,"eighty":-0.432231,"marketCap":66096885},{"date":"2024-03-15","current":-0.730103,"twenty":-3.500919,"median":-0.648502,"eighty":-0.435038,"marketCap":61680146},{"date":"2024-03-22","current":-0.808945,"twenty":-3.480396,"median":-0.652377,"eighty":-0.435836,"marketCap":68288733},{"date":"2024-03-28","current":-1.054383,"twenty":-3.473393,"median":-0.654869,"eighty":-0.436123,"marketCap":88665209},{"date":"2024-04-05","current":-1.179969,"twenty":-3.465214,"median":-0.658098,"eighty":-0.440275,"marketCap":99128806},{"date":"2024-04-12","current":-1.259189,"twenty":-3.444462,"median":-0.660278,"eighty":-0.443139,"marketCap":105737393},{"date":"2024-04-19","current":-1.407563,"twenty":-3.420656,"median":-0.672034,"eighty":-0.443489,"marketCap":83754210},{"date":"2024-04-26","current":-1.259398,"twenty":-3.378137,"median":-0.676202,"eighty":-0.44479,"marketCap":74937977},{"date":"2024-05-03","current":-1.435344,"twenty":-3.320017,"median":-0.681097,"eighty":-0.44561,"marketCap":85407253},{"date":"2024-05-10","current":-1.32422,"twenty":-3.279006,"median":-0.684378,"eighty":-0.446408,"marketCap":78795079},{"date":"2024-05-17","current":-1.592768,"twenty":-3.260823,"median":-0.693504,"eighty":-0.447635,"marketCap":94774500},{"date":"2024-05-24","current":-1.666851,"twenty":-3.254831,"median":-0.701012,"eighty":-0.448794,"marketCap":99182617},{"date":"2024-05-31","current":-1.449234,"twenty":-3.249419,"median":-0.704085,"eighty":-0.449278,"marketCap":86233775},{"date":"2024-06-07","current":-1.518686,"twenty":-3.238835,"median":-0.706334,"eighty":-0.4494,"marketCap":90366384},{"date":"2024-06-14","current":-1.555727,"twenty":-3.224366,"median":-0.708791,"eighty":-0.449677,"marketCap":92570442},{"date":"2024-06-21","current":-1.340148,"twenty":-3.190715,"median":-0.71884,"eighty":-0.450315,"marketCap":79742824},{"date":"2024-06-28","current":-1.185316,"twenty":-3.183833,"median":-0.721224,"eighty":-0.450774,"marketCap":70529861},{"date":"2024-07-05","current":-1.240878,"twenty":-3.170454,"median":-0.723582,"eighty":-0.451545,"marketCap":73835948},{"date":"2024-07-12","current":-1.176056,"twenty":-3.143988,"median":-0.729841,"eighty":-0.451982,"marketCap":69978846},{"date":"2024-07-15","current":-1.157535,"twenty":-3.129748,"median":-0.729947,"eighty":-0.452091,"marketCap":68876817},{"date":"2024-08-02","current":-1.092713,"twenty":-3.115508,"median":-0.730052,"eighty":-0.452201,"marketCap":65019715},{"date":"2024-08-09","current":-0.98159,"twenty":-3.014673,"median":-0.736133,"eighty":-0.452774,"marketCap":58407541},{"date":"2024-08-16","current":-1.092713,"twenty":-2.961387,"median":-0.739819,"eighty":-0.45309,"marketCap":65019715},{"date":"2024-08-23","current":-0.935288,"twenty":-2.949349,"median":-0.74874,"eighty":-0.453588,"marketCap":55652468},{"date":"2024-08-30","current":-1.185316,"twenty":-2.923043,"median":-0.750977,"eighty":-0.454471,"marketCap":70529861},{"date":"2024-09-06","current":-1.101881,"twenty":-2.824357,"median":-0.754751,"eighty":-0.455485,"marketCap":65565220},{"date":"2024-09-13","current":-3.101255,"twenty":-3.038791,"median":-0.760755,"eighty":-0.458405,"marketCap":66304838},{"date":"2024-09-20","current":-3.20308,"twenty":-3.135439,"median":-0.764942,"eighty":-0.461887,"marketCap":68481847},{"date":"2024-09-27","current":-3.643975,"twenty":-3.178787,"median":-0.768625,"eighty":-0.462897,"marketCap":77908185},{"date":"2024-10-04","current":-3.786116,"twenty":-3.214164,"median":-0.768787,"eighty":-0.463358,"marketCap":80947156},{"date":"2024-10-11","current":-3.256318,"twenty":-3.2512,"median":-0.769748,"eighty":-0.463499,"marketCap":69620080},{"date":"2024-10-18","current":-3.20463,"twenty":-3.255304,"median":-0.777696,"eighty":-0.46412,"marketCap":68514999},{"date":"2024-10-25","current":-3.152943,"twenty":-3.2512,"median":-0.778868,"eighty":-0.46532,"marketCap":67409919},{"date":"2024-10-31","current":-3.023724,"twenty":-3.252492,"median":-0.779597,"eighty":-0.466029,"marketCap":64647217},{"date":"2024-11-08","current":-2.920349,"twenty":-3.246435,"median":-0.78225,"eighty":-0.467418,"marketCap":62437056},{"date":"2024-11-15","current":-2.558536,"twenty":-3.240854,"median":-0.784347,"eighty":-0.469438,"marketCap":54701491},{"date":"2024-11-22","current":-2.558794,"twenty":-3.232318,"median":-0.791102,"eighty":-0.471718,"marketCap":54707017},{"date":"2024-11-29","current":-2.739442,"twenty":-3.230474,"median":-0.795022,"eighty":-0.47267,"marketCap":58569273},{"date":"2024-12-06","current":-2.584379,"twenty":-3.230474,"median":-0.797467,"eighty":-0.473741,"marketCap":55254032},{"date":"2024-12-13","current":-2.972036,"twenty":-3.221554,"median":-0.799781,"eighty":-0.47387,"marketCap":63542136},{"date":"2024-12-20","current":-2.564997,"twenty":-3.20463,"median":-0.803647,"eighty":-0.474921,"marketCap":54839626},{"date":"2024-12-27","current":-2.506848,"twenty":-3.20463,"median":-0.806207,"eighty":-0.475039,"marketCap":53596411},{"date":"2025-01-03","current":-3.127099,"twenty":-3.2114,"median":-0.808052,"eighty":-0.475596,"marketCap":66857378},{"date":"2025-01-10","current":-2.881583,"twenty":-3.20463,"median":-0.808945,"eighty":-0.47631,"marketCap":61608245},{"date":"2025-01-17","current":-2.698092,"twenty":-3.20463,"median":-0.815352,"eighty":-0.478446,"marketCap":57685209},{"date":"2025-01-24","current":-2.765286,"twenty":-3.20432,"median":-0.816837,"eighty":-0.481062,"marketCap":59121814},{"date":"2025-01-31","current":-2.506848,"twenty":-3.200607,"median":-0.819848,"eighty":-0.481972,"marketCap":53596411},{"date":"2025-02-07","current":-2.713598,"twenty":-3.188329,"median":-0.826287,"eighty":-0.482087,"marketCap":58016733},{"date":"2025-02-14","current":-2.506848,"twenty":-3.178787,"median":-0.830851,"eighty":-0.482431,"marketCap":53596411},{"date":"2025-02-21","current":-2.222566,"twenty":-3.178787,"median":-0.833977,"eighty":-0.482982,"marketCap":47518467},{"date":"2025-02-28","current":-2.323357,"twenty":-3.178787,"median":-0.836434,"eighty":-0.483597,"marketCap":49673374},{"date":"2025-03-07","current":-2.145035,"twenty":-3.178787,"median":-0.841825,"eighty":-0.483604,"marketCap":45860846},{"date":"2025-03-14","current":-2.196464,"twenty":-3.17351,"median":-0.847958,"eighty":-0.485805,"marketCap":46960401},{"date":"2025-03-21","current":-2.132888,"twenty":-3.158228,"median":-0.854887,"eighty":-0.486637,"marketCap":45601152},{"date":"2025-03-28","current":-1.964128,"twenty":-3.152943,"median":-0.866854,"eighty":-0.487368,"marketCap":41993064},{"date":"2025-04-04","current":-2.085992,"twenty":-3.152943,"median":-0.871306,"eighty":-0.488722,"marketCap":32599878},{"date":"2025-04-11","current":-2.262418,"twenty":-3.152943,"median":-0.875775,"eighty":-0.489198,"marketCap":35357074},{"date":"2025-04-17","current":-2.939585,"twenty":-3.152943,"median":-0.881739,"eighty":-0.490836,"marketCap":45939842},{"date":"2025-04-25","current":-2.739481,"twenty":-3.132268,"median":-0.886194,"eighty":-0.49207,"marketCap":42812612},{"date":"2025-05-02","current":-2.904169,"twenty":-3.127099,"median":-0.891223,"eighty":-0.492327,"marketCap":45386350},{"date":"2025-05-09","current":-2.798273,"twenty":-3.106424,"median":-0.899784,"eighty":-0.492888,"marketCap":43731409},{"date":"2025-05-16","current":-2.338518,"twenty":-3.101255,"median":-0.908751,"eighty":-0.493355,"marketCap":40238874},{"date":"2025-05-23","current":-2.650534,"twenty":-3.101255,"median":-0.914348,"eighty":-0.493529,"marketCap":45607747},{"date":"2025-05-30","current":-2.509001,"twenty":-3.092719,"median":-0.916163,"eighty":-0.493996,"marketCap":43172382},{"date":"2025-06-06","current":-2.518927,"twenty":-3.072615,"median":-0.918616,"eighty":-0.494949,"marketCap":43343179},{"date":"2025-06-12","current":-2.644534,"twenty":-3.0628,"median":-0.920472,"eighty":-0.495453,"marketCap":45504504}],"updateTime":1749833702827}}}